Cyclooxygenase‐2 Inhibition and Anti‐Platelet Aggregation Activity of Astaxanthin‐Hydrogel in Comparison to Celecoxib Against Rheumatoid Arthritis in Wistar Rat Model

Biopharmaceutics and Drug Disposition · Published 2026-02-24 · DOI 10.1002/bdd.70027

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1002/bdd.70027

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Exploring the Potential of Nasal Drug Delivery for Brain Targeted Therapy: A Detailed Analysis · Biopharmaceutics and Drug Disposition · 2024 · Same journal
• Gender difference in the pharmacokinetics and metabolism of VX‐548 in rats · Biopharmaceutics and Drug Disposition · 2024 · Same journal
• Across‐Species Meta‐Analysis of Betamethasone Pharmacokinetics Utilizing a Minimal PBPK Model · Biopharmaceutics and Drug Disposition · 2025 · Same journal
• Coming full circle: The potential utility of real‐world evidence to discern predictions from a physiologically based pharmacokinetic model · Biopharmaceutics and Drug Disposition · 2023 · Same journal
• Selective inhibitory effects of suberosin on CYP1A2 in human liver microsomes · Biopharmaceutics and Drug Disposition · 2023 · Same journal
• Pharmacokinetic control of orally dosed cyclosporine A with mucosal drug delivery system · Biopharmaceutics and Drug Disposition · 2024 · Same journal
• Icaritin exhibits potential drug–drug interactions through the inhibition of human UDP‐glucuronosyltransferase in vitro · Biopharmaceutics and Drug Disposition · 2024 · Same journal
• Aging and brain free cholesterol concentration on amyloid‐β peptide accumulation in guinea pigs · Biopharmaceutics and Drug Disposition · 2024 · Same journal
• Effect of Curcuminoids on Pharmacokinetics and Pharmacodynamics of Atorvastatin in Hyperlipidemia Rats and Its Potential Mechanism · Biopharmaceutics and Drug Disposition · 2025 · Same journal
• A Novel Slowly Self‐Emulsifying Drug Delivery System: Prolonged Systemic Exposure of Tacrolimus With Reduced Risks of Systemic Side Effects · Biopharmaceutics and Drug Disposition · 2026 · Same journal